Device Trial Radar · NCT01284283
2-Year Post-Approval Study to Investigate the Scandinavian Total Ankle Replacement System (STAR) Ankle Under Actual Conditions of Use
Last checked: Nov 20, 2026Latest source record: Jul 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
102
Actual
Start
Nov 2009
Primary completion
Mar 2021
Study completion Mar 2021
Sponsor
- Lead sponsor
- Encore Medical, L.P.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 26, 2011
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This post-approval study is being conducted to examine the performance of the STAR Ankle under actual conditions of use.
Conditions
- Primary Arthrosis
- Post Traumatic Arthritis
- Rheumatoid Arthritis
- Osteoarthritis
Interventions
Scandinavian Total Ankle Replacement System (STAR Ankle)Device
For total ankle replacement
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary EndpointTime frame: 2 years
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
The CORE Institute
Phoenix, Arizona
Cedars Sinai Medical Center
Los Angeles, California
Palo Alto Medical Research Foundation (Sutter Health)
Palo Alto, California
6 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.